Tirdzniecība DexCom, Inc. - DXCM CFD
Pievienot izlasei- Kopsavilkums
- Vēsturiskie Dati
- Notikumi
- Peļņas Atskaite
- Bilance
- Naudas Plūsma
- Īpašums
Starpība | 0.25 | ||||||||
Garās pozīcijas nodeva naktij
Long position overnight fee
Doties uz platformu | -0.030779% | ||||||||
Īsās pozīcijas nodeva naktij
Short position overnight fee
Doties uz platformu | -0.013666% | ||||||||
Nakts laika nodeva | 22:00 (UTC) | ||||||||
Min. tirgotais daudzums | 1 | ||||||||
Valūta | USD | ||||||||
Drošības rezerve | 20% | ||||||||
Fondu birža | United States of America | ||||||||
Tirdzniecības komisija | 0% |
*Information provided by Capital.com
Dexcom Inc ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Iepriekš. aizvērt* | 106.63 |
Atvērt* | 104.92 |
Izmaiņas par 1 gadu* | -75.21% |
Dienas Diapazons* | 104.67 - 109.54 |
52 ned Diapazons | 66.89-134.77 |
Vidējais apjoms (10 dienas) | 2.50M |
Vidējais apjoms (3 mēneši) | 51.60M |
Tirgus Kapitalizācija | 41.88B |
Cenas/Peļņas Attiecība | 202.53 |
Izvietotās Akcijas | 386.26M |
Ieņēmumi | 2.79B |
EPS | 0.54 |
Dividende (Ienesīgums %) | N/A |
Beta | 1.10 |
Nākamās Peļņas Datums | Feb 9, 2023 |
"Visus datus nodrošina Refinitiv, izņemot datus, kas atzīmēti ar zvaigznīti, kas ir *dati, kurus nodrošina Capital.com"
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Aizvēršana | Change | Change (%) | Atvēršana | High | Low |
---|---|---|---|---|---|---|
Feb 6, 2023 | 106.63 | -0.90 | -0.84% | 107.53 | 108.92 | 106.26 |
Feb 3, 2023 | 108.28 | 2.05 | 1.93% | 106.23 | 109.84 | 105.23 |
Feb 2, 2023 | 107.90 | 0.32 | 0.30% | 107.58 | 110.31 | 106.42 |
Feb 1, 2023 | 107.51 | 0.41 | 0.38% | 107.10 | 108.48 | 103.89 |
Jan 31, 2023 | 106.93 | 1.92 | 1.83% | 105.01 | 107.47 | 104.88 |
Jan 30, 2023 | 105.41 | 0.30 | 0.29% | 105.11 | 106.79 | 104.90 |
Jan 27, 2023 | 106.60 | 1.74 | 1.66% | 104.86 | 107.65 | 104.40 |
Jan 26, 2023 | 106.51 | 1.61 | 1.53% | 104.90 | 106.94 | 103.66 |
Jan 25, 2023 | 103.92 | 0.84 | 0.81% | 103.08 | 104.87 | 102.36 |
Jan 24, 2023 | 105.89 | 0.74 | 0.70% | 105.15 | 106.36 | 102.52 |
Jan 23, 2023 | 106.25 | -0.75 | -0.70% | 107.00 | 108.73 | 105.87 |
Jan 20, 2023 | 107.72 | 1.88 | 1.78% | 105.84 | 107.91 | 104.65 |
Jan 19, 2023 | 106.01 | 0.12 | 0.11% | 105.89 | 107.57 | 105.56 |
Jan 18, 2023 | 106.54 | -2.35 | -2.16% | 108.89 | 110.13 | 106.33 |
Jan 17, 2023 | 109.39 | 2.37 | 2.21% | 107.02 | 109.54 | 105.38 |
Jan 13, 2023 | 108.28 | 2.72 | 2.58% | 105.56 | 108.52 | 104.94 |
Jan 12, 2023 | 107.03 | 1.74 | 1.65% | 105.29 | 108.38 | 103.20 |
Jan 11, 2023 | 106.04 | -5.64 | -5.05% | 111.68 | 112.32 | 104.94 |
Jan 10, 2023 | 110.78 | 2.23 | 2.05% | 108.55 | 111.86 | 107.67 |
Jan 9, 2023 | 109.89 | -1.90 | -1.70% | 111.79 | 113.12 | 107.21 |
DexCom, Inc. Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- Ikgadējs
- Ceturkšņa
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Kopējie ienākumi | 573.3 | 718.5 | 1031.6 | 1476 | 1926.7 | 2448.5 |
Ienākumi | 573.3 | 718.5 | 1031.6 | 1476 | 1926.7 | 2448.5 |
Cost of Revenue, Total | 194.9 | 226.4 | 367.7 | 530.4 | 622.2 | 739.9 |
Bruto Peļņa | 378.4 | 492.1 | 663.9 | 945.6 | 1304.5 | 1708.6 |
Kopējie Darbības Izdevumi | 637.2 | 761 | 1217.9 | 1333.7 | 1633.1 | 2184.2 |
Pārdošanas/Vispārīgi/Admin. Izdevumi, Kopā | 286.2 | 349.2 | 432.8 | 515.7 | 620.7 | 810.5 |
Pētniecība un Attīstība | 156.1 | 185.4 | 417.4 | 273.5 | 359.9 | 604.2 |
Darbības Izdevumi | -63.9 | -42.5 | -186.3 | 142.3 | 293.6 | 264.3 |
Ienākumi no Procentiem (Izdevumi), Neto, ar Darbību Nesaistītie | -0.3 | -9.5 | 59.8 | -38.1 | -68.6 | -90.4 |
Citi, Neto | -0.7 | 3.4 | ||||
Neto Ienākumi Pirms Nodokļu Nomaksas | -64.9 | -48.6 | -126.5 | 104.2 | 225 | 173.9 |
Neto Ienākumi Pēc Nodokļu Nomaksas | -65.6 | 55.5 | -127.5 | 101.1 | 493.6 | 154.7 |
Neto Ienākumi Pirms Ārkārtas Posteņiem | -65.6 | 55.5 | -127.5 | 101.1 | 493.6 | 154.7 |
Neto Ienākumi | -65.6 | -50.2 | -127.1 | 101.1 | 493.6 | 154.7 |
Kopējie Ienākumi, Izņemot Ārkārtas Posteņus | -65.6 | 55.5 | -127.5 | 101.1 | 493.6 | 154.7 |
Kopējie Ienākumi, Ieskaitot Ārkārtas Posteņus | -65.6 | -50.2 | -127.1 | 101.1 | 493.6 | 154.7 |
Atšķaidītie Neto Ienākumi | -65.6 | -50.2 | -127.1 | 101.1 | 493.6 | 154.7 |
Atšķaidītie Ienākumi par Akcijām | 334.4 | 345.2 | 352.8 | 369.2 | 390 | 400.4 |
Atšķaidītie Ienākumi, Izņemot Ārkārtas Posteņus | -0.19617 | 0.16078 | -0.36139 | 0.27384 | 1.26564 | 0.38636 |
Dividends per Share - Common Stock Primary Issue | 0 | |||||
Atšķaidītā Normalizētā Peļņa par Akciju | -0.19617 | 0.18149 | -0.35145 | 0.33848 | 1.33881 | 0.50656 |
Ārkārtas Posteņi Kopā | -105.7 | 0.4 | 0 | |||
Neparedzēti Izdevumi (Ienākumi) | 14.1 | 30.3 | 29.6 |
Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
---|---|---|---|---|---|
Kopējie ienākumi | 505 | 595.1 | 650.2 | 698.2 | 628.8 |
Ienākumi | 505 | 595.1 | 650.2 | 698.2 | 628.8 |
Cost of Revenue, Total | 161.1 | 178 | 203.3 | 197.5 | 230.7 |
Bruto Peļņa | 343.9 | 417.1 | 446.9 | 500.7 | 398.1 |
Kopējie Darbības Izdevumi | 459.1 | 494.1 | 532.7 | 698.3 | 587.5 |
Pārdošanas/Vispārīgi/Admin. Izdevumi, Kopā | 188.6 | 187 | 199.8 | 235.1 | 220.9 |
Pētniecība un Attīstība | 109.4 | 129.1 | 128.8 | 236.9 | 135.9 |
Darbības Izdevumi | 45.9 | 101 | 117.5 | -0.1 | 41.3 |
Ienākumi no Procentiem (Izdevumi), Neto, ar Darbību Nesaistītie | -4.6 | -24.3 | -26.8 | -14.6 | -5.2 |
Neto Ienākumi Pirms Nodokļu Nomaksas | 41.3 | 76.7 | 90.7 | -14.7 | 36.1 |
Neto Ienākumi Pēc Nodokļu Nomaksas | 56.5 | 62.9 | 70.9 | -19.4 | 97.3 |
Neto Ienākumi Pirms Ārkārtas Posteņiem | 56.5 | 62.9 | 70.9 | -19.4 | 97.3 |
Neto Ienākumi | 56.5 | 62.9 | 70.9 | -19.4 | 97.3 |
Kopējie Ienākumi, Izņemot Ārkārtas Posteņus | 56.5 | 62.9 | 70.9 | -19.4 | 97.3 |
Kopējie Ienākumi, Ieskaitot Ārkārtas Posteņus | 56.5 | 62.9 | 70.9 | -19.4 | 97.3 |
Atšķaidītie Neto Ienākumi | 56.5 | 62.9 | 70.9 | -19.4 | 97.3 |
Atšķaidītie Ienākumi par Akcijām | 418.4 | 398.4 | 402 | 388 | 428.8 |
Atšķaidītie Ienākumi, Izņemot Ārkārtas Posteņus | 0.13504 | 0.15788 | 0.17637 | -0.05 | 0.22691 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Atšķaidītā Normalizētā Peļņa par Akciju | 0.13504 | 0.15788 | 0.17792 | -0.00175 | 0.22691 |
Neparedzēti Izdevumi (Ienākumi) | 0 | 0.8 | 28.8 |
- Ikgadējs
- Ceturkšņa
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Apgrozāmo Līdzekļu Kopsumma | 280 | 744.7 | 1699.5 | 1969.4 | 3424.8 | 3684.4 |
Nauda un Īstermiņa Ieguldījumi | 123.7 | 548.6 | 1385.6 | 1533.3 | 2707.7 | 2731.2 |
Nauda un Ekvivalenti | 94.5 | 441.5 | 1137 | 446.2 | 817.6 | 1052.6 |
Īstermiņa Ieguldījumi | 29.2 | 107.1 | 248.6 | 1087.1 | 1890.1 | 1678.6 |
Debitoru Parādu Kopsumma, Neto | 101.7 | 134.3 | 226.7 | 286.3 | 428.5 | 514.3 |
Accounts Receivable - Trade, Net | 101.7 | 134.3 | 226.7 | 286.3 | 428.5 | 514.3 |
Total Inventory | 45.4 | 45.2 | 70.7 | 119.8 | 234.7 | 357.3 |
Prepaid Expenses | 9.2 | 16.6 | 16.5 | 30 | 53.9 | 81.6 |
Total Assets | 402.8 | 904.1 | 1916 | 2395 | 4290.5 | 4933.3 |
Property/Plant/Equipment, Total - Net | 109.4 | 145.6 | 183.1 | 392.8 | 608.6 | 889.9 |
Property/Plant/Equipment, Total - Gross | 156.6 | 200.4 | 262.9 | 497.8 | 762.8 | 1121.4 |
Accumulated Depreciation, Total | -47.2 | -54.8 | -79.8 | -105 | -154.2 | -231.5 |
Goodwill, Net | 11.3 | 12.1 | 18.7 | 18.6 | 19.3 | 26.5 |
Intangibles, Net | 0.2 | 31.5 | ||||
Other Long Term Assets, Total | 1.9 | 1.7 | 14.7 | 14.2 | 237.8 | 301 |
Total Current Liabilities | 102.4 | 138.9 | 222.4 | 360.2 | 614.1 | 720.8 |
Accounts Payable | 24.5 | 46.7 | 75.5 | 102.3 | 163.3 | 189.4 |
Accrued Expenses | 77 | 89 | 144 | 255.6 | 439.8 | 514.3 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0 | 0.6 | 8.8 | |||
Other Current Liabilities, Total | 0.9 | 3.2 | 2.9 | 1.7 | 2.2 | 17.1 |
Total Liabilities | 119 | 484.7 | 1252.7 | 1512.4 | 2464 | 2891.2 |
Total Long Term Debt | 6 | 334.3 | 1017.6 | 1074.1 | 1721.2 | 2038.8 |
Long Term Debt | 0 | 327.6 | 1010.3 | 1059.7 | 1667.2 | 1981.8 |
Capital Lease Obligations | 6 | 6.7 | 7.3 | 14.4 | 54 | 57 |
Other Liabilities, Total | 10.6 | 11.5 | 12.7 | 78.1 | 128.7 | 125.7 |
Total Equity | 283.8 | 419.4 | 663.3 | 882.6 | 1826.5 | 2042.1 |
Redeemable Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
Additional Paid-In Capital | 905.7 | 1093.7 | 1560.6 | 1675.9 | 2125.3 | 2109 |
Retained Earnings (Accumulated Deficit) | -621 | -671.8 | -798.9 | -695.7 | -202.1 | 138.7 |
Other Equity, Total | -1 | -2.6 | 1.5 | 2.3 | 3.2 | 0.5 |
Total Liabilities & Shareholders’ Equity | 402.8 | 904.1 | 1916 | 2395 | 4290.5 | 4933.3 |
Total Common Shares Outstanding | 338.4 | 348 | 360 | 366.4 | 384.4 | 388 |
Treasury Stock - Common | -100 | -100 | -100 | -206.2 | ||
Deferred Income Tax | 5.9 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Apgrozāmo Līdzekļu Kopsumma | 3445.1 | 3474.2 | 3656.2 | 3684.4 | 3746.6 |
Nauda un Īstermiņa Ieguldījumi | 2632.6 | 2584.9 | 2697.9 | 2731.2 | 2688.2 |
Nauda un Ekvivalenti | 733.8 | 1158.8 | 1444.3 | 1052.6 | 716 |
Īstermiņa Ieguldījumi | 1898.8 | 1426.1 | 1253.6 | 1678.6 | 1972.2 |
Debitoru Parādu Kopsumma, Neto | 443.4 | 483.5 | 529.1 | 514.3 | 544.5 |
Accounts Receivable - Trade, Net | 443.4 | 483.5 | 529.1 | 514.3 | 544.5 |
Total Inventory | 289.7 | 319.3 | 351.3 | 357.3 | 342.2 |
Prepaid Expenses | 79.4 | 86.5 | 77.9 | 81.6 | 171.7 |
Total Assets | 4389.8 | 4503.8 | 4775.9 | 4933.3 | 5057 |
Property/Plant/Equipment, Total - Net | 688.7 | 770.8 | 833.5 | 889.9 | 938.8 |
Property/Plant/Equipment, Total - Gross | 860.7 | 957.6 | 1036.5 | 1121.4 | 1203.7 |
Accumulated Depreciation, Total | -172 | -186.8 | -203 | -231.5 | -264.9 |
Goodwill, Net | 18.9 | 19.1 | 23.9 | 26.5 | 26.6 |
Other Long Term Assets, Total | 237.1 | 239.7 | 238.9 | 301 | 313.6 |
Total Current Liabilities | 604.1 | 600.7 | 734.9 | 720.8 | 711.4 |
Accounts Payable | 152.2 | 165.9 | 210 | 189.4 | 150.1 |
Accrued Expenses | 450 | 433 | 522.6 | 514.3 | 558.6 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 1.9 | 1.8 | 2.3 | 17.1 | 2.7 |
Total Liabilities | 2486.6 | 2506.2 | 2639.8 | 2891.2 | 2867.7 |
Total Long Term Debt | 1743 | 1768.1 | 1761.3 | 2038.8 | 2027.5 |
Long Term Debt | 1688.8 | 1710.7 | 1703.5 | 1981.8 | 1965.9 |
Capital Lease Obligations | 54.2 | 57.4 | 57.8 | 57 | 61.6 |
Other Liabilities, Total | 139.5 | 137.4 | 143.6 | 125.7 | 122.7 |
Total Equity | 1903.2 | 1997.6 | 2136.1 | 2042.1 | 2189.3 |
Redeemable Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
Additional Paid-In Capital | 2162 | 2193.6 | 2322.1 | 2109 | 1996.6 |
Retained Earnings (Accumulated Deficit) | -161.8 | -98.9 | -28 | 138.7 | 236 |
Treasury Stock - Common | -100 | -100 | -159.5 | -206.2 | -37.3 |
Other Equity, Total | 2.9 | 2.8 | 1.4 | 0.5 | -6.1 |
Total Liabilities & Shareholders’ Equity | 4389.8 | 4503.8 | 4775.9 | 4933.3 | 5057 |
Total Common Shares Outstanding | 386.8 | 386.8 | 387.6 | 388 | 392.4 |
Intangibles, Net | 23.4 | 31.5 | 31.4 | ||
Deferred Income Tax | 5.9 | 6.1 |
- Ikgadējs
- Ceturkšņa
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Neto ienākumi/Sākuma Līnija | -65.6 | -50.2 | -127.1 | 101.1 | 493.6 | 154.7 |
Nauda no Darbības | 56.2 | 92 | 123.2 | 314.5 | 475.6 | 442.5 |
Nauda no Darbības | 15 | 16.1 | 29.1 | 48.7 | 67.1 | 102 |
Bezskaidras Naudas Preces | 113.1 | 123.5 | 262.1 | 158.6 | 213 | 322.7 |
Cash Taxes Paid | 0.1 | 1.4 | 2.3 | 4.8 | 3.6 | 16.8 |
Samaksātie Procenti Naudā | 0.1 | 2.4 | 3.6 | 10.4 | 10.6 | 11.6 |
Izmaiņas Apgrozāmajā Kapitālā | -6.3 | 2.6 | -40.9 | 6.1 | -20.8 | -132 |
Nauda no Ieguldījumu Darbībām | -55.9 | -144.4 | -139.8 | -1015.2 | -1018 | -216.1 |
Kapitālie Izdevumi | -55.7 | -66 | -67.1 | -180 | -199 | -389.2 |
Citi Ieguldījumu Naudas Plūsmas Posteņi, Kopā | -0.2 | -78.4 | -72.7 | -835.2 | -819 | 173.1 |
Nauda no Darbībām ar Finansēšanu | 8.1 | 399.1 | 710.4 | 10.7 | 912.1 | 10.4 |
Akciju Izsniegšana (Atkāpšanās), Neto | 10.4 | 10.1 | 94.6 | 11.9 | 15.3 | 20.3 |
Parādu Izsniegšana (Atkāpšanās), Neto | -2.3 | 389 | 617.7 | 0 | 906.2 | 0 |
Neto Izmaiņas Naudā | 8.4 | 347 | 695.6 | -690.7 | 371.8 | 235.4 |
Ārvalstu Valūtas Ietekme | 0.3 | 1.8 | -0.7 | 2.1 | -1.4 | |
Naudas Plūsma Finansēšanas Posteņos | -1.9 | -1.2 | -9.4 | -9.9 | ||
Deferred Taxes | -277.3 | -4.9 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 40.3 | 103.2 | 174.1 | 154.7 | 97.3 |
Cash From Operating Activities | 27.8 | 89.4 | 336.7 | 442.5 | 71 |
Cash From Operating Activities | 20.9 | 44.4 | 69.9 | 102 | 36.8 |
Deferred Taxes | -0.3 | 0.1 | 0.2 | -4.9 | 0.1 |
Non-Cash Items | 58.2 | 120.3 | 185.1 | 322.7 | 34.3 |
Changes in Working Capital | -91.3 | -178.6 | -92.6 | -132 | -97.5 |
Cash From Investing Activities | -112.2 | 251 | 280 | -216.1 | -411.8 |
Capital Expenditures | -99.7 | -200.9 | -309 | -389.2 | -101.6 |
Other Investing Cash Flow Items, Total | -12.5 | 451.9 | 589 | 173.1 | -310.2 |
Cash From Financing Activities | 0.8 | 0.4 | 11.2 | 10.4 | 5.3 |
Financing Cash Flow Items | -7.9 | -8.3 | -9.1 | -9.9 | -4.8 |
Issuance (Retirement) of Stock, Net | 8.7 | 8.7 | 20.3 | 20.3 | 10.1 |
Foreign Exchange Effects | -0.4 | 0.1 | -0.9 | -1.4 | -1 |
Net Change in Cash | -84 | 340.9 | 627 | 235.4 | -336.5 |
Issuance (Retirement) of Debt, Net | 0 | 0 | 0 |
Investora vārds | Investora veids | Nenokārtots procents | Akcijas turējumā | Izmaiņas akcijās | Turēšanas termiņš | Apgrozījuma reitings |
---|---|---|---|---|---|---|
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 11.263 | 43504103 | 506655 | 2022-09-30 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 5.6274 | 21736347 | -75610 | 2022-09-30 | LOW |
Baillie Gifford & Co. | Investment Advisor | 4.4796 | 17302885 | -802293 | 2022-12-31 | LOW |
Sands Capital Management, LLC | Investment Advisor | 4.3218 | 16693318 | -1208895 | 2022-09-30 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 4.2437 | 16391712 | 156880 | 2022-09-30 | LOW |
Capital Research Global Investors | Investment Advisor | 2.7262 | 10530238 | 2847171 | 2022-09-30 | LOW |
Fidelity Management & Research Company LLC | Investment Advisor | 2.5609 | 9891601 | -119599 | 2022-09-30 | LOW |
Wellington Management Company, LLP | Investment Advisor/Hedge Fund | 2.3422 | 9047009 | 3297715 | 2022-09-30 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 2.0751 | 8015184 | 192962 | 2022-09-30 | LOW |
Nuveen LLC | Pension Fund | 2.0577 | 7948042 | 209503 | 2022-09-30 | LOW |
JP Morgan Asset Management | Investment Advisor | 1.8817 | 7268168 | -646636 | 2022-09-30 | LOW |
Jennison Associates LLC | Investment Advisor/Hedge Fund | 1.7976 | 6943376 | -1620235 | 2022-09-30 | LOW |
ClearBridge Investments, LLC | Investment Advisor/Hedge Fund | 1.4004 | 5408974 | -298536 | 2022-09-30 | LOW |
Invesco Capital Management (QQQ Trust) | Investment Advisor | 1.2947 | 5000766 | -151984 | 2023-01-31 | LOW |
Janus Henderson Investors | Investment Advisor/Hedge Fund | 1.265 | 4886021 | -1210023 | 2022-09-30 | LOW |
William Blair & Company, L.L.C. (Research) | Research Firm | 1.1965 | 4621748 | 119780 | 2022-09-30 | LOW |
Voya Investment Management LLC | Investment Advisor/Hedge Fund | 1.1531 | 4454124 | 1510296 | 2022-09-30 | MED |
Capital World Investors | Investment Advisor | 0.9751 | 3766229 | 47344 | 2022-09-30 | LOW |
Macquarie Investment Management | Investment Advisor | 0.9446 | 3648714 | 374085 | 2022-09-30 | LOW |
T. Rowe Price Associates, Inc. | Investment Advisor | 0.8992 | 3473151 | -620387 | 2022-09-30 | LOW |
Kāpēc izvēlēties Capital.com? Mūsu skaitļi runā paši par sevi.
Capital.com GroupTirgotāji
Ikmēneša aktīvie klienti
Ikmēneša ieguldījumu apjoms
Izņemts katru mēnesi
Treidinga kalkulators
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
DexCom Company profile
Par DexCom, Inc.
DexCom, Inc. ir medicīnas ierīču uzņēmums. Uzņēmums galvenokārt koncentrējas uz nepārtrauktas glikozes monitorēšanas (CGM) sistēmu projektēšanu, izstrādi un komercializāciju, kas paredzētas diabēta slimniekiem un veselības aprūpes pakalpojumu sniedzējiem. Dexcom G6 ir CGM sistēma, ko var izmantot kā daļu no integrētas sistēmas ar citām saderīgām medicīnas ierīcēm un elektroniskām saskarnēm, kas var ietvert automatizētas insulīna dozēšanas sistēmas, insulīna sūkņus, glikozes mērītājus vai citas elektroniskas ierīces, kuras izmanto diabēta vadībai. Dexcom Share attālinātās uzraudzības sistēma, kas tiek piedāvāta lietošanai kopā ar Dexcom sistēmu, izmanto lietojumprogrammu pacienta mobilajā ierīcē, lai bezvadu režīmā pārsūtītu glikozes informāciju uz mākoni un pēc tam uz lietojumprogrammām līdz pat pieciem norādītiem saņēmējiem mobilajās ierīcēs. Tās Dexcom Real-Time API ļauj uzaicinātajiem trešo pušu izstrādātājiem integrēt reāllaika CGM datus savās digitālajās veselības lietojumprogrammās un ierīcēs. Citi uzņēmuma produkti ir Dexcom ONE un Dexcom G7.
Industry: | Medical Equipment, Supplies & Distribution (NEC) |
6340 Sequence Dr
SAN DIEGO
CALIFORNIA 92121
US
Peļņas Atskaite
- Annual
- Quarterly
Cilvēki arī skatās
Vai joprojām meklējat mākleri, kuram varat uzticēties?
Pievienojieties 500 000+ tirgotājiem visā pasaulē, kuri izvēlējās tirgoties ar Capital.com